Marshall Wace North America’s Inspire Medical Systems INSP Stock Holding History

Marshall Wace North America’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$74.7M	Sell	320,657 -134,406	-30%	-$28M	0.32%	65
2021 Q2	$87.9M	Buy	455,063 +131,828	+41%	+$26.1M	0.37%	56
2021 Q1	$66.9M	Buy	+323,235	New	+$68.7M	0.28%	78
2020 Q1	–	Sell	-6,024	Closed	-$447K	–	1405
2019 Q4	$447K	Buy	+6,024	New	+$387K	﹤0.01%	847
2019 Q2	–	Sell	-800	Closed	-$45K	–	1351
2019 Q1	$45K	Buy	+800	New	+$43.2K	﹤0.01%	1280
2018 Q3	–	Sell	-26,150	Closed	-$933K	–	1126
2018 Q2	$933K	Buy	+26,150	New	+$844K	0.01%	945

Other funds holding INSP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Marshall Wace North America's INSP Position: Q3 2021 in Review

Marshall Wace North America reduced its Inspire Medical Systems (INSP) stake by 30% in Q3 2021, selling an estimated $28M and leaving 320,657 shares worth $74.7M. The position accounts for 0.32% of the portfolio, ranked #65.

Marshall Wace North America first reported a position in INSP in Q2 2018 and has held it in 6 quarters since. The position peaked at $87.9M in Q2 2021. 253 funds tracked by Wall St. Rank hold INSP as of Q3 2021.

Marshall Wace North America held 320,657 shares of Inspire Medical Systems worth $74.7M as of Q3 2021.
Marshall Wace North America sold 134,406 Inspire Medical Systems shares in Q3 2021, an estimated $28M.
Inspire Medical Systems made up 0.32% of Marshall Wace North America's portfolio in Q3 2021, its #65 holding.
Marshall Wace North America first reported a position in Inspire Medical Systems in Q2 2018 and has held it in 6 quarters since.
Marshall Wace North America's Inspire Medical Systems position peaked at $87.9M in Q2 2021.
253 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.